Diabetes & Metabolism

Papers
(The TQCC of Diabetes & Metabolism is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Contents - page 1109
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France98
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study76
Editorial board47
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department39
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report39
Are GLP-1 receptor agonists and diabetic retinopathy foes or friends?37
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial36
Contents32
Editorial board32
The significance of ophthalmological evaluation in the correct diagnosis of pediatric insulin-dependent diabetes mellitus: lessons from novel WFS1 variants31
Association between adipose deposition and mortality among adults without major cardiovascular risk factors31
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood31
Reduced risks of colorectal cancer with GLP-1RAs in type 2 diabetes: A nationwide cohort study using a target trial emulation framework29
Diabetic retinopathy remission in patients using an automated insulin delivery system: A prospective controlled study29
Body weight trends in individuals with type 1 diabetes using automated insulin delivery vs. traditional insulin pumps28
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients27
Pancreatic polypeptide in patients with type 1 diabetes and exocrine failure or chronic pancreatitis. The DIAPP study26
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–202126
Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations26
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”25
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review24
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis24
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes23
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–202022
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes22
Concise review of lipidomics in nonalcoholic fatty liver disease20
Sommaire19
Contents19
1-h post-load plasma glucose for detecting early stages of prediabetes18
Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study18
Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999-201818
Type B insulin resistance syndrome: A case report17
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability16
Modelled substitution of meat with dairy products and the 20-year cumulative incidence of type 2 diabetes: Insights from the ATTICA cohort study (2002–2022)16
Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study16
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT15
Averaged glycaemic variability or by average: More than a simple question of wording15
Contents15
Efficacy and safety of pharmacological treatments for gestational diabetes: a systematic review comparing metformin with glibenclamide and insulin15
Correspondence for “Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring”14
Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study14
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes14
Glucose management indicator: Do we need device-specific equations?13
Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study13
Editorial board13
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications13
Conduction disturbances in Type 1 and Type 2 Diabetes in two large independent nationwide and international databases12
Contents - Page 112
Transitions in metabolic health status over time and risk of heart failure: A prospective study12
Peripheral neuropathy as a bedside marker for cerebral microangiopathy12
Monitoring gestational diabetes mellitus patients with myDiabby Healthcare® smartphone application vs classical diary. Results from the non-inferiority TELESUR-GDM study12
Diabetes prevalence, awareness, and control in the United States, 2017-202312
Editorial board12
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction12
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease12
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach11
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes11
Glucagon like peptide-1 receptor agonists in type 1 diabetes11
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus11
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design11
Association of podocyte ultrastructural changes with proteinuria and pathological classification in type 2 diabetic nephropathy11
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention11
Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease11
Contents11
Contents - page 110
Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance10
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography10
"Usefulness of continuous interstitial glucose in diabetic patient undergoing hemodialysis10
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus10
Editorial board10
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV rand10
Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders10
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis9
Association between smoking status and suicide mortality in patients with type 2 diabetes: A nationwide population-based cohort study9
Secukinumab (Anti-IL-17) induces clinical regression in early diagnosed type 1 diabetes: A case report9
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study9
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs9
Contents9
Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults9
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus9
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals9
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States9
Impact of different types of hypertensive disorders of pregnancy and their duration on incident post-partum risk of diabetes mellitus: Results from the French nationwide study CONCEPTION8
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists8
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan8
Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort8
Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease8
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus8
Is Omnipod 5 cost effective for the management of type 1 diabetes among adults in France?8
Editorial board8
Effect of dietary reinforcement combined or not with GLP-1 receptor agonist therapy on histological outcomes in MASLD among patients with type 2 diabetes8
0.21268796920776